SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-457541
Filing Date
2012-11-07
Accepted
2012-11-07 16:30:34
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d399021d10q.htm 10-Q 730785
2 EX-31.1 d399021dex311.htm EX-31.1 7313
3 EX-31.2 d399021dex312.htm EX-31.2 7312
4 EX-32.1 d399021dex321.htm EX-32.1 4111
5 EX-32.2 d399021dex322.htm EX-32.2 4090
  Complete submission text file 0001193125-12-457541.txt   4188255

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hptx-20120930.xml EX-101.INS 531264
7 XBRL TAXONOMY EXTENSION SCHEMA hptx-20120930.xsd EX-101.SCH 42931
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hptx-20120930_cal.xml EX-101.CAL 46991
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hptx-20120930_def.xml EX-101.DEF 106248
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hptx-20120930_lab.xml EX-101.LAB 294528
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hptx-20120930_pre.xml EX-101.PRE 220832
Mailing Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-745-7802
HYPERION THERAPEUTICS INC (Filer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35614 | Film No.: 121187182
SIC: 2834 Pharmaceutical Preparations